OMCL stock forecast
Our latest prediction for Omnicell, Inc.'s stock price was made on the April 3, 2020 when the stock price was at 65.23$.
In the short term (2weeks), OMCL's stock price should underperform the market by -0.71%. During that period the price should oscillate between -6.70% and +9.60%.
In the medium term (3months), OMCL's stock price should underperform the market by -0.41%. During that period the price should oscillate between -15.93% and +22.11%.
Get email alertsCreate a solid portfolio with OMCL
About Omnicell, Inc.
Omnicell, Inc. engages in the provision of medication management automation solutions and adherence tools for healthcare systems and pharmacies. Its solutions include intelligence; platform and interoperability; central pharmacy dispensing; medication adherence; population health; and point of care automation. The company was founded by Randall A. Lipps in September 1992 and is headquartered in Mountain View, CA.
At the moment the company generates 897M USD in revenues.
On its last earning announcement, the company reported a profit of 1.43$ per share.
The book value per share is 14.99$
Three months stock forecastApril 3, 2020
Financials
| Revenue USD | Gross Margin | Operating Income | Operating Margin | Net Income | Earnings Per Share | Dividends | Payout Ratio | Shares | Book Value Per Share | Operating Cash Flow | Cap Spending | Free Cash Flow |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 897M | 48.70% | 78M | 8.69% | 61M | 1.43 | - | - | 43M | 14.99 | 145M | -62M | 83M |